Advertisement

Topics

FDA Approval for Olaratumab for Soft Tissue Sarcoma

11:09 EDT 19 Oct 2016 | Medscape

The novel drug blocks platelet-derived growth factor (PDGF) receptors, which may help to slow or stop tumor growth; it is approved for use with doxorubicin.
FDA Approvals

Original Article: FDA Approval for Olaratumab for Soft Tissue Sarcoma

NEXT ARTICLE

More From BioPortfolio on "FDA Approval for Olaratumab for Soft Tissue Sarcoma"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...